
zzso zzso with humanized zzso targeting vascular zzso growth factor zzso or orally active small zzso zzso zzso targeting zzso receptors has become an established treatment zzso for various forms of zzso A common side effect of zzso zzso is the development of sometimes severe hypertension, which simultaneously appears to be zzso for a favorable zzso zzso 

Since zzso increases the expression and activity of zzso zzso oxide zzso it has been assumed that the mean blood pressure zzso rise during zzso zzso is caused by a decrease in zzso oxide zzso Yet, the results from experimental and clinical studies exploring this possibility are zzso Recent studies provided evidence that the zzso rise during zzso zzso rather is zzso by zzso of the zzso zzso zzso which, among others, zzso zzso zzso Nevertheless, conclusive evidence for the involvement of zzso oxygen species in the zzso rise could not be obtained so zzso 

The mechanism underlying zzso of the zzso axis during zzso zzso is zzso and this zzso was not anticipated in view of studies showing that zzso stimulates both the expression and production of zzso by zzso zzso 

In fact, this zzso of the zzso axis may support the use of zzso zzso zzso for the treatment of zzso zzso hypertension, especially because zzso zzso stimulation in vascular smooth muscle cells results in zzso production and zzso in a zzso protein zzso zzso zzso 

